NANH_VIBC3
ID NANH_VIBC3 Reviewed; 781 AA.
AC A5F7A4; C3M1H8; P37060; Q9KR59;
DT 18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT 18-MAR-2008, sequence version 2.
DT 03-AUG-2022, entry version 91.
DE RecName: Full=Sialidase;
DE EC=3.2.1.18;
DE AltName: Full=Neuraminidase;
DE Short=NANase;
DE Flags: Precursor;
GN Name=nanH; OrderedLocusNames=VC0395_A1381, VC395_1898;
OS Vibrio cholerae serotype O1 (strain ATCC 39541 / Classical Ogawa 395 /
OS O395).
OC Bacteria; Proteobacteria; Gammaproteobacteria; Vibrionales; Vibrionaceae;
OC Vibrio.
OX NCBI_TaxID=345073;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX PubMed=1730470; DOI=10.1128/iai.60.2.406-415.1992;
RA Galen J.E., Ketley J.M., Fasano A., Richardson S.H., Wasserman S.S.,
RA Kaper J.B.;
RT "Role of Vibrio cholerae neuraminidase in the function of cholera toxin.";
RL Infect. Immun. 60:406-415(1992).
RN [2]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=ATCC 39541 / Classical Ogawa 395 / O395;
RA Heidelberg J.;
RL Submitted (MAR-2007) to the EMBL/GenBank/DDBJ databases.
RN [3]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=ATCC 39541 / Classical Ogawa 395 / O395;
RX PubMed=19115014; DOI=10.1371/journal.pone.0004053;
RA Feng L., Reeves P.R., Lan R., Ren Y., Gao C., Zhou Z., Ren Y., Cheng J.,
RA Wang W., Wang J., Qian W., Li D., Wang L.;
RT "A recalibrated molecular clock and independent origins for the cholera
RT pandemic clones.";
RL PLoS ONE 3:E4053-E4053(2008).
RN [4]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-44, AND PROTEIN SEQUENCE OF 25-44.
RX PubMed=2832365; DOI=10.1128/jb.170.4.1495-1504.1988;
RA Vimr E.R., Lawrisuk L., Galen J.E., Kaper J.B.;
RT "Cloning and expression of the Vibrio cholerae neuraminidase gene nanH in
RT Escherichia coli.";
RL J. Bacteriol. 170:1495-1504(1988).
CC -!- FUNCTION: Cleaves the terminal sialic acid (N-acetyl neuraminic acid)
CC from carbohydrate chains in glycoproteins providing free sialic acid
CC which can be used as carbon and energy sources. Sialidases have been
CC suggested to be pathogenic factors in microbial infections. Facilitates
CC cholera toxin binding to host intestinal epithelial cells by converting
CC cell surface polysialogangliosides to GM1 monogangliosides.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=Hydrolysis of alpha-(2->3)-, alpha-(2->6)-, alpha-
CC (2->8)- glycosidic linkages of terminal sialic acid residues in
CC oligosaccharides, glycoproteins, glycolipids, colominic acid and
CC synthetic substrates.; EC=3.2.1.18;
CC -!- COFACTOR:
CC Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250};
CC -!- SUBUNIT: Monomer. {ECO:0000250}.
CC -!- SUBCELLULAR LOCATION: Secreted.
CC -!- INDUCTION: May be controlled by sialic acid availability and a growth-
CC phase-dependent mechanism.
CC -!- SIMILARITY: Belongs to the glycosyl hydrolase 33 family. {ECO:0000305}.
CC -!- SEQUENCE CAUTION:
CC Sequence=ABQ19703.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC Sequence=ACP09894.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; M83562; AAA27546.1; -; Genomic_DNA.
DR EMBL; CP000627; ABQ19703.1; ALT_INIT; Genomic_DNA.
DR EMBL; CP001235; ACP09894.1; ALT_INIT; Genomic_DNA.
DR EMBL; M19268; AAA27547.1; -; Genomic_DNA.
DR PIR; A27734; A27734.
DR PIR; A43866; A43866.
DR RefSeq; WP_001211290.1; NZ_JAACZH010000016.1.
DR AlphaFoldDB; A5F7A4; -.
DR SMR; A5F7A4; -.
DR STRING; 345073.VC395_1898; -.
DR CAZy; CBM40; Carbohydrate-Binding Module Family 40.
DR CAZy; GH33; Glycoside Hydrolase Family 33.
DR EnsemblBacteria; ABQ19703; ABQ19703; VC0395_A1381.
DR GeneID; 57740427; -.
DR KEGG; vco:VC0395_A1381; -.
DR KEGG; vcr:VC395_1898; -.
DR PATRIC; fig|345073.21.peg.1838; -.
DR eggNOG; COG4409; Bacteria.
DR HOGENOM; CLU_376807_0_0_6; -.
DR Proteomes; UP000000249; Chromosome 2.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0052794; F:exo-alpha-(2->3)-sialidase activity; IEA:UniProtKB-EC.
DR GO; GO:0052795; F:exo-alpha-(2->6)-sialidase activity; IEA:UniProtKB-EC.
DR GO; GO:0052796; F:exo-alpha-(2->8)-sialidase activity; IEA:UniProtKB-EC.
DR GO; GO:0033691; F:sialic acid binding; IEA:InterPro.
DR GO; GO:0008152; P:metabolic process; IEA:UniProtKB-KW.
DR InterPro; IPR013320; ConA-like_dom_sf.
DR InterPro; IPR011040; Sialidase.
DR InterPro; IPR026856; Sialidase_fam.
DR InterPro; IPR036278; Sialidase_sf.
DR InterPro; IPR015344; VCNA_lectin-like_dom.
DR PANTHER; PTHR10628; PTHR10628; 1.
DR Pfam; PF13088; BNR_2; 1.
DR Pfam; PF09264; Sial-lect-inser; 2.
DR SUPFAM; SSF49899; SSF49899; 2.
DR SUPFAM; SSF50939; SSF50939; 1.
PE 1: Evidence at protein level;
KW Calcium; Direct protein sequencing; Glycosidase; Hydrolase; Repeat;
KW Secreted; Signal.
FT SIGNAL 1..24
FT /evidence="ECO:0000269|PubMed:2832365"
FT CHAIN 25..781
FT /note="Sialidase"
FT /id="PRO_0000323013"
FT REPEAT 263..274
FT /note="BNR 1"
FT REPEAT 585..596
FT /note="BNR 2"
FT REPEAT 653..664
FT /note="BNR 3"
FT REPEAT 718..729
FT /note="BNR 4"
FT ACT_SITE 250
FT /note="Proton acceptor"
FT /evidence="ECO:0000250"
FT ACT_SITE 619
FT /evidence="ECO:0000255"
FT ACT_SITE 740
FT /note="Nucleophile"
FT /evidence="ECO:0000250"
FT BINDING 224
FT /ligand="substrate"
FT /evidence="ECO:0000250"
FT BINDING 635
FT /ligand="substrate"
FT /evidence="ECO:0000250"
FT BINDING 712
FT /ligand="substrate"
FT /evidence="ECO:0000250"
FT CONFLICT 22
FT /note="S -> L (in Ref. 4; AAA27547)"
FT /evidence="ECO:0000305"
SQ SEQUENCE 781 AA; 85609 MW; FA85ED907FB20AF0 CRC64;
MRFKNVKKTA LMLAMFGMAT SSNAALFDYN ATGDTEFDSP AKQGWMQDNT NNGSGVLTNA
DGMPAWLVQG IGGRAQWTYS LSTNQHAQAS SFGWRMTTEM KVLSGGMITN YYANGTQRVL
PIISLDSSGN LVVEFEGQTG RTVLATGTAA TEYHKFELVF LPGSNPSASF YFDGKLIRDN
IQPTASKQNM IVWGNGSSNT DGVAAYRDIK FEIQGDVIFR GPDRIPSIVA SSVTPGVVTA
FAEKRVGGGD PGALSNTNDI ITRTSRDGGI TWDTELNLTE QINVSDEFDF SDPRPIYDPS
SNTVLVSYAR WPTDAAQNGD RIKPWMPNGI FYSVYDVASG NWQAPIDVTD QVKERSFQIA
GWGGSELYRR NTSLNSQQDW QSNAKIRIVD GAANQIQVAD GSRKYVVTLS IDESGGLVAN
LNGVSAPIIL QSEHAKVHSF HDYELQYSAL NHTTTLFVDG QQITTWAGEV SQENNIQFGN
ADAQIDGRLH VQKIVLTQQG HNLVEFDAFY LAQQTPEVEK DLEKLGWTKI KTGNTMSLYG
NASVNPGPGH GITLTRQQNI SGSQNGRLIY PAIVLDRFFL NVMSIYSDDG GSNWQTGSTL
PIPFRWKSSS ILETLEPSEA DMVELQNGDL LLTARLDFNQ IVNGVNYSPR QQFLSKDGGI
TWSLLEANNA NVFSNISTGT VDASITRFEQ SDGSHFLLFT NPQGNPAGTN GRQNLGLWFS
FDEGVTWKGP IQLVNGASAY SDIYQLDSEN AIVIVETDNS NMRILRMPIT LLKQKLTLSQ
N